Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 May;34(5):733–738. doi: 10.1128/aac.34.5.733

Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.

Y H Tsai 1, M Bies 1, F Leitner 1, R E Kessler 1
PMCID: PMC171682  PMID: 2360814

Abstract

Cefepime (BMY 28142) was compared with ceftazidime, cefotaxime, and moxalactam for efficacy in treating experimental meningitis in mice and neonatal rats. Mice were infected intracranially with Streptococcus pneumoniae, S. agalactiae, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa and treated intramuscularly. Five- to eight-day-old neonatal rats were injected intracisternally with Haemophilus influenzae, S. pneumoniae, and S. agalactiae and treated intraperitoneally. Cefepime was found to be the most active compound against induced meningitis in mice infected with S. agalactiae. Cefepime was as active as cefotaxime against Staphylococcus aureus meningitis, slightly more active than cefotaxime against S. pneumoniae and E. coli, and as active as ceftazidime against K. pneumoniae and P. aeruginosa meningitis. Cefepime was found to be the most active compound against S. pneumoniae and S. agalactiae meningitis in neonatal rats. Against H. influenzae, cefepime was as active as moxalactam and cefotaxime. Ceftazidime was the least active compound. The pharmacokinetics of cefepime in neonatal rats were similar to those of ceftazidime. Both compounds penetrated well into cerebrospinal fluid and brain tissues of uninfected neonatal rats. Relative concentrations were twice as high as those of cefotaxime and moxalactam.

Full text

PDF
736

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Ho D. H., LeBlanc B. In vitro studies of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1985 Feb;27(2):265–269. doi: 10.1128/aac.27.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bortolussi R., Ferrieri P., Wannamaker L. W. Dynamics of Escherichia coli infection and meningitis in infant rats. Infect Immun. 1978 Nov;22(2):480–485. doi: 10.1128/iai.22.2.480-485.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cordera C. S., Pekarek R. S. Treatment of experimental Haemophilus influenzae type b meningitis with 1-oxa-beta-lactam (LY127935). Antimicrob Agents Chemother. 1980 Feb;17(2):258–262. doi: 10.1128/aac.17.2.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Ferrieri P., Burke B., Nelson J. Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes. Infect Immun. 1980 Mar;27(3):1023–1032. doi: 10.1128/iai.27.3.1023-1032.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fuchs P. C., Jones R. N., Barry A. L., Thornsberry C. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother. 1985 May;27(5):679–682. doi: 10.1128/aac.27.5.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kessler R. E., Bies M., Buck R. E., Chisholm D. R., Pursiano T. A., Tsai Y. H., Misiek M., Price K. E., Leitner F. Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics. Antimicrob Agents Chemother. 1985 Feb;27(2):207–216. doi: 10.1128/aac.27.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kim K. S., Bayer A. S. Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci. Antimicrob Agents Chemother. 1985 Jul;28(1):51–54. doi: 10.1128/aac.28.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kim K. S., Manocchio M., Bayer A. S. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats. Chemotherapy. 1984;30(4):262–269. doi: 10.1159/000238278. [DOI] [PubMed] [Google Scholar]
  9. Masuyoshi S., Hiraoka M., Inoue M., Tomatsu K., Hirano M., Mitsuhashi S. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime. Drugs Exp Clin Res. 1989;15(1):1–10. [PubMed] [Google Scholar]
  10. McColm A. A., Ryan D. M. Therapeutic activity of ceftazidime and eleven other beta-lactam antibiotics against experimental Haemophilus influenzae, type b meningitis. J Antimicrob Chemother. 1984 May;13(5):517–520. doi: 10.1093/jac/13.5.517. [DOI] [PubMed] [Google Scholar]
  11. Moxon E. R., Smith A. L., Averill D. R., Smith D. H. Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis. 1974 Feb;129(2):154–162. doi: 10.1093/infdis/129.2.154. [DOI] [PubMed] [Google Scholar]
  12. Naito T., Aburaki S., Kamachi H., Narita Y., Okumura J., Kawaguchi H. Synthesis and structure-activity relationships of a new series of cephalosporins, BMY-28142 and related compounds. J Antibiot (Tokyo) 1986 Aug;39(8):1092–1107. doi: 10.7164/antibiotics.39.1092. [DOI] [PubMed] [Google Scholar]
  13. Smith A. L., Smith D. H., Averill D. R., Jr, Marino J., Moxon E. R. Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun. 1973 Aug;8(2):278–290. doi: 10.1128/iai.8.2.278-290.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Steele J. C., Jr, Edwards B. H., Rissing J. P. In-vitro activity of BMY 28142, a new aminothiazolyl cephalosporin. J Antimicrob Chemother. 1985 Oct;16(4):463–468. doi: 10.1093/jac/16.4.463. [DOI] [PubMed] [Google Scholar]
  15. Tomatsu K., Ando S., Masuyoshi S., Hirano M., Miyaki T., Kawaguchi H. Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin. J Antibiot (Tokyo) 1986 Nov;39(11):1584–1591. doi: 10.7164/antibiotics.39.1584. [DOI] [PubMed] [Google Scholar]
  16. Tsai Y. H., Williams E. B., Hirth R. S., Price K. E. Pneumococcal meningitis-therapeutic studies in mice. Chemotherapy. 1975;21(6):342–357. doi: 10.1159/000221879. [DOI] [PubMed] [Google Scholar]
  17. Täuber M. G., Hackbarth C. J., Scott K. G., Rusnak M. G., Sande M. A. New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits. Antimicrob Agents Chemother. 1985 Mar;27(3):340–342. doi: 10.1128/aac.27.3.340. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES